EUVIMEDEUVIMED entdecken
Crossref

Disseminated intravascular coagulation is an underestimated but fatal adverse event associated with blinatumomab therapy: A pharmacovigilance analysis of FAERS

Zhiqiang Song, Yang Wang iD, Dongliang Zhang, Tao Wang iD, Na Liu, Lei Gao, Libing Wang, Jianmin Yang iD

International Journal of Cancer · 2025

DOI: 10.1002/ijc.35235 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Cancer, 2025. Verfasst von Zhiqiang Song und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hematology, Institute of Hematology, Shanghai Changhai Hospital, Naval Medical University, Shanghai, China. Hauptthemen laut MEDLINE: Antibodies, Bispecific, Pharmacovigilance, Disseminated Intravascular Coagulation. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 49 Literaturangaben. Gefördert von: Youth Start-up Foundation of the First Affiliated Hospital of Second Military Medical University, Changzheng Hospital "Pyramid Talent Project", Changhai hospital "Changfeng" Project.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Hematologic adverse events (AEs) are common and serious toxicities in patients with hematologic malignancies undergoing blinatumomab therapy. However, restrictive selection criteria in pivotal clinical trials can lead to an underestimation of rare but fatal toxicities. In this study, we systematically analyzed hematologic AEs associated with blinatumomab using the Food and Drug Administration Adverse Event Reporting System (FAERS) from October 2014 to December 2023. Disproportionate analysis was performed to identify overreported AEs, with a reporting odds ratio (ROR), and a lower bound of the 95% confidence interval (ROR 025 ) exceeding one considered significant. Additionally, adjusted mortality rates and risk ratios (RR) of the top 10 reported hematologic AEs were calculated using a logistic regression model. Among 4745 blinatumomab‐related cases, 418 (8.81%) involved hematologic AEs. We identified 22 significantly overreporting hematologic AEs compared to the full database, with myelosuppression ( n = 39 [9.33%], ROR 025 = 8.04), disseminated intravascular coagulation (DIC, n = 31 [7.42%], ROR 025 = 15.14), and bone marrow failure ( n = 14 [3.35%], ROR 025 = 3.41) notably underestimated in clinical trials. DIC resulted in a substantial mortality rate of 45.16%. Finally, DIC was found to be independently associated with death in a multivariable logistic regression analysis (RR = 2.47 [95% CI: 1.11–3.83]). These findings could aid clinicians in the early detection of these rarely reported but fatal hematologic AEs, thereby reducing the risk of severe toxicities in blinatumomab recipients.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antibodies, BispecificPharmacovigilanceDisseminated Intravascular CoagulationHumansFemaleMaleMiddle AgedAgedAdultUnited StatesAdverse Drug Reaction Reporting SystemsAntineoplastic AgentsHematologic NeoplasmsUnited States Food and Drug AdministrationYoung Adult

Stichwörter der Autor:innen

FAERSblinatumomabdisseminated intravascular coagulationhematologic AEs

Substanzen

Antibodies, BispecificblinatumomabAntineoplastic Agents

Autor:innen und Institutionen

  • Department of Hematology, Institute of Hematology, Shanghai Changhai Hospital, Naval Medical University, Shanghai, China.
  • Department of Hematology, Myeloma & Lymphoma Center, Shanghai Changzheng Hospital, Naval Medical University, Shanghai, China.
  • Department of Hematology, The 909th Hospital, School of Medicine, Xiamen University, Zhangzhou, Xiamen, China.

ORCID-Profile: Yang Wang, Tao Wang, Jianmin Yang

Förderung

  • Youth Start-up Foundation of the First Affiliated Hospital of Second Military Medical University
  • Changzheng Hospital "Pyramid Talent Project"
  • Changhai hospital "Changfeng" Project
  • Shanghai 2021 "Action Plan of Technological Innovation" Biomedical Science and Technology Support Special Project
  • Medical-enterprise Integration Innovation and Collaboration Project
  • National Natural Science Foundation of China

Zitieren

APA

Song, Z., Wang, Y., Zhang, D., Wang, T., Liu, N., Gao, L., Wang, L., & Yang, J. (2025). Disseminated intravascular coagulation is an underestimated but fatal adverse event associated with blinatumomab therapy: A pharmacovigilance analysis of FAERS. International Journal of Cancer. https://doi.org/10.1002/ijc.35235

Vancouver

Song Z, Wang Y, Zhang D, Wang T, Liu N, Gao L, et al. Disseminated intravascular coagulation is an underestimated but fatal adverse event associated with blinatumomab therapy: A pharmacovigilance analysis of FAERS. International Journal of Cancer. 2025. doi:10.1002/ijc.35235

BibTeX
@article{Song2025,
  author = {Song, Zhiqiang and Wang, Yang and Zhang, Dongliang and Wang, Tao and Liu, Na and Gao, Lei and Wang, Libing and Yang, Jianmin},
  title = {Disseminated intravascular coagulation is an underestimated but fatal adverse event associated with blinatumomab therapy: A pharmacovigilance analysis of FAERS},
  journal = {International Journal of Cancer},
  year = {2025},
  doi = {10.1002/ijc.35235}
}
Kostenlos starten →